• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24657
Device Problems Premature Activation (1484); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/27/2023
Event Type  malfunction  
Event Description
It was reported that the stent premature deployed.This 6x150, 130 cm eluvia drug-eluting vascular stent system was selected for use in a lower extremity angiogram for peripheral artery disease.It was noted that a contralateral approach was used for the procedure.The stent prematurely deployed in the sheath.The sheath was removed, and re-access of the artery was performed.The procedure was completed using a new stent.The patient fully recovered.
 
Manufacturer Narrative
Device eval by manufacturer: upon receipt at our post market quality assurance laboratory, it was found that the delivery sheath was not returned for analysis.Visual examination revealed that the stent was damaged and stuck inside an unknown sheath.The stent appeared to have been separated and the distal section was missing.Microscopic examination revealed no additional damages.X ray examination of the sheath revealed that the proximal section of the stent was completely inside the introducer sheath.The struts could be visualized damaged inside the sheath.Inspection of the remainder of the device revealed no other damage or irregularities.Product analysis confirmed that the stent was deployed inside a sheath.
 
Event Description
It was reported that the stent premature deployed.This 6x150, 130 cm eluvia drug-eluting vascular stent system was selected for use in a lower extremity angiogram for peripheral artery disease.It was noted that a contralateral approach was used for the procedure.The stent prematurely deployed in the sheath.The sheath was removed, and re-access of the artery was performed.The procedure was completed using a new stent.The patient fully recovered.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17542263
MDR Text Key321087385
Report Number2124215-2023-43360
Device Sequence Number1
Product Code NIU
UDI-Device Identifier08714729876625
UDI-Public08714729876625
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P180011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/20/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/14/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number24657
Device Catalogue Number24657
Device Lot Number0030898823
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/13/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/16/2022
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-